Then, we classified IGFBP5 expression in KIRP patients by patient gender, age, race, histologic subtype and cancer stage and found significant differences in IGFBP5 expression between the normal controls and all the subgroups (Figures 1(b)–1(f)). This evidence concerns the gene IGFBP5 and cancer.